176 related articles for article (PubMed ID: 16087795)
1. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.
van Royen N; Schirmer SH; Atasever B; Behrens CY; Ubbink D; Buschmann EE; Voskuil M; Bot P; Hoefer I; Schlingemann RO; Biemond BJ; Tijssen JG; Bode C; Schaper W; Oskam J; Legemate DA; Piek JJ; Buschmann I
Circulation; 2005 Aug; 112(7):1040-6. PubMed ID: 16087795
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps.
Grundmann S; Hoefer I; Ulusans S; Bode C; Oesterle S; Tijssen JG; Piek JJ; Buschmann I; van Royen N
J Vasc Surg; 2006 Jun; 43(6):1263-9. PubMed ID: 16765251
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease.
Zbinden S; Zbinden R; Meier P; Windecker S; Seiler C
J Am Coll Cardiol; 2005 Nov; 46(9):1636-42. PubMed ID: 16256861
[TBL] [Abstract][Full Text] [Related]
4. Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial.
van Royen N; Piek JJ; Legemate DA; Schaper W; Oskam J; Atasever B; Voskuil M; Ubbink D; Schirmer SH; Buschmann I; Bode C; Buschmann EE
Vasc Med; 2003; 8(3):191-6. PubMed ID: 14989560
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor.
Buschmann IR; Busch HJ; Mies G; Hossmann KA
Circulation; 2003 Aug; 108(5):610-5. PubMed ID: 12835229
[TBL] [Abstract][Full Text] [Related]
6. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction.
Deng Z; Yang C; Deng H; Yang A; Geng T; Chen X; Ma A; Liu Z
Int J Cardiol; 2006 Oct; 113(1):92-6. PubMed ID: 16891014
[TBL] [Abstract][Full Text] [Related]
7. Myocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease: a controlled randomized trial.
Meier P; Gloekler S; de Marchi SF; Indermuehle A; Rutz T; Traupe T; Steck H; Vogel R; Seiler C
Circulation; 2009 Oct; 120(14):1355-63. PubMed ID: 19770393
[TBL] [Abstract][Full Text] [Related]
8. [Arterial remodeling at the reference site after angioplasty and the effect of granulocyte-macrophage colony-stimulating factor on remodeling].
Ma XJ; Zhang XH; Chen B; Shang DY; Zhou Y; Zhu GY; Shao JH
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2566-9. PubMed ID: 19080653
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factor.
Rini BI; Fong L; Weinberg V; Kavanaugh B; Small EJ
J Urol; 2006 Jun; 175(6):2087-91. PubMed ID: 16697809
[TBL] [Abstract][Full Text] [Related]
10. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation.
Cho HJ; Kim HS; Lee MM; Kim DH; Yang HJ; Hur J; Hwang KK; Oh S; Choi YJ; Chae IH; Oh BH; Choi YS; Walsh K; Park YB
Circulation; 2003 Dec; 108(23):2918-25. PubMed ID: 14568896
[TBL] [Abstract][Full Text] [Related]
11. Effects of granulocyte-macrophage colony stimulating factor on the repair of vessel intima damaged by balloon.
Zhang XH; Ma XJ; Zhao T
Chin Med J (Engl); 2005 Feb; 118(3):220-5. PubMed ID: 15740651
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease.
Subramaniyam V; Waller EK; Murrow JR; Manatunga A; Lonial S; Kasirajan K; Sutcliffe D; Harris W; Taylor WR; Alexander RW; Quyyumi AA
Am Heart J; 2009 Jul; 158(1):53-60.e1. PubMed ID: 19540392
[TBL] [Abstract][Full Text] [Related]
13. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
Santos JB; de Jesus AR; Machado PR; Magalhães A; Salgado K; Carvalho EM; Almeida RP
J Infect Dis; 2004 Nov; 190(10):1793-6. PubMed ID: 15499535
[TBL] [Abstract][Full Text] [Related]
14. [Effect of granulocyte-macrophage colony stimulating factor on the repair of vessel intima damaged by balloon].
Zhang XH; Ma XJ; Zhao T
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):635-7. PubMed ID: 15949364
[TBL] [Abstract][Full Text] [Related]
15. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
[TBL] [Abstract][Full Text] [Related]
16. Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial.
Poole J; Mavromatis K; Binongo JN; Khan A; Li Q; Khayata M; Rocco E; Topel M; Zhang X; Brown C; Corriere MA; Murrow J; Sher S; Clement S; Ashraf K; Rashed A; Kabbany T; Neuman R; Morris A; Ali A; Hayek S; Oshinski J; Yoon YS; Waller EK; Quyyumi AA
JAMA; 2013 Dec; 310(24):2631-9. PubMed ID: 24247554
[TBL] [Abstract][Full Text] [Related]
17. The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats.
Kucuk C; Ozkan M; Akgun H; Muhtaroglu S; Sozuer E
J Surg Res; 2005 Sep; 128(1):15-20. PubMed ID: 15975592
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
19. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma.
Mels AK; Statius Muller MG; van Leeuwen PA; von Blomberg BM; Scheper RJ; Cuesta MA; Beelen RH; Meijer S
Br J Surg; 2001 Apr; 88(4):539-44. PubMed ID: 11298622
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
